# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jefferies analyst Brian Tanquilut downgrades Enhabit (NYSE:EHAB) from Buy to Hold and lowers the price target from $14 to $8...
Believes Enhabit's Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified In...
GUIDANCEThe Company reaffirmed its full-year 2024 guidance as follows: ($ in millions, except per share data)2024 Guidance Net...
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced Enhabit's Board of Directors (the ...
Enhabit (NYSE:EHAB) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 per...
TD Cowen analyst Ryan Langston maintains Enhabit (NYSE:EHAB) with a Market Perform and lowers the price target from $12 to $11.
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...